
Overview
Availability
- Associate Professor Helmut Schaider is:
- Available for supervision
Qualifications
- Bachelor of Medicine, Karl-Franzens- Universität Graz
- Certificate of Dermatology, Australasian College of Dermatologists
Works
Search Professor Helmut Schaider’s works on UQ eSpace
2024
Journal Article
Trial protocol for SiroSkin: a randomised double-blind placebo-controlled trial of topical sirolimus in chemoprevention of facial squamous cell carcinomas in solid organ transplant recipients
Dousset, Lea, Chambers, Daniel C., Webster, Angela, Isbel, Nicole, Campbell, Scott, Duarte, Carla, Collins, Louisa, Damian, Diona, Tseng, Anne, Karlsen, Emma, Ilinsky, Olga Victoria, Brown, Susan, Schaider, Helmut, Soyer, H. Peter, Ospino, Daniel Ariza, Hogarth, Sam, Chong, Alvin H., Mar, Victoria, McKenzie, Scott, Gin, Douglas, Fernandez-Penas, Pablo, Kern, Johannes S., Loewe, Katja, Roy, Edwige, Herschtal, Alan and Khosrotehrani, Kiarash (2024). Trial protocol for SiroSkin: a randomised double-blind placebo-controlled trial of topical sirolimus in chemoprevention of facial squamous cell carcinomas in solid organ transplant recipients. Trials, 25 (1) 789. doi: 10.1186/s13063-024-08619-3
2024
Journal Article
Cyclic tachyplesin I kills proliferative, non-proliferative and drug-resistant melanoma cells without inducing resistance
Benfield, Aurélie H., Vernen, Felicitas, Young, Reuben S.E., Nadal-Bufí, Ferran, Lamb, Henry, Hammerlindl, Heinz, Craik, David J., Schaider, Helmut, Lawrence, Nicole, Blanksby, Stephen J. and Henriques, Sónia Troeira (2024). Cyclic tachyplesin I kills proliferative, non-proliferative and drug-resistant melanoma cells without inducing resistance. Pharmacological Research, 207 107298, 107298. doi: 10.1016/j.phrs.2024.107298
2024
Conference Publication
Environmentally stressed drug-naive melanoma cell subpopulations share a molecular signature with drug-induced early persister cells
Kangachar, S. Asgharzadeh, Ahmed, F., Al Emran, A., Boyle, G., Spoerri, L., Schaider, H. and Haass, N. K. (2024). Environmentally stressed drug-naive melanoma cell subpopulations share a molecular signature with drug-induced early persister cells. Society for Investigative Dermatology (SID) 2024 Meeting, Dallas, TX, United States, 15-18 May 2024. Oxford, United Kingdom: Elsevier.
2024
Conference Publication
Environmentally stressed drug-naïve melanoma cell subpopulations share a molecular signature with drug-induced early persister cells
Kangachar, S. Asgharzadeh, Ahmed, F., Al Emran, A., Boyle, G., Spoerri, L., Schaider, H. and Haass, N.K. (2024). Environmentally stressed drug-naïve melanoma cell subpopulations share a molecular signature with drug-induced early persister cells. Society for Investigative Dermatology (SID) 2024 Meeting, Dallas, TX United States, 15-18 May 2024. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2024.06.641
2024
Conference Publication
A calcium influx pathway regulates adaptive melanoma drug tolerance
Guan, Yimeng, Robitaille, Melanie, Torrano, Joachim, Haass, Nikolas, Roberts-Thomson, Sarah, Monteith, Gregory and Schaider, Helmut (2024). A calcium influx pathway regulates adaptive melanoma drug tolerance. ASDR 2024 Annual Scientific Meeting, Sydney, NSW Australia, 18-20 July 2024.
2024
Conference Publication
Exploring calcium signalling remodelling during adaptive cancer drug tolerance
Robitaille, Melanie, Schaider, Helmut, Monteith, Gregory and Roberts-Thomson, Sarah (2024). Exploring calcium signalling remodelling during adaptive cancer drug tolerance. Calcium Signaling- Gordon Research Conference, Barga, Lucca, Italy, 30 June - 5 July 2024.
2024
Conference Publication
O-GlcNAc transferase drives the proliferative state in adaptive drug tolerance
Menon, Dinoop Ravindran, Hammerlindl, Heinz, Gimenez, Gregory, Zuegner, Elmar, Magens, Christoph, Eccles, Michael, Fujita, Mayumi and Schaider, Helmut (2024). O-GlcNAc transferase drives the proliferative state in adaptive drug tolerance. AACR Annual Meeting 2024, San Diego, CA United States, 5-10 April 2024. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2024-lb293
2023
Conference Publication
Exploring calcium signalling remodelling during adaptive cancer drug tolerance
Robitaille, Mélanie, Schaider, Helmut, Roberts-Thomson, Sarah and Monteith, Gregory (2023). Exploring calcium signalling remodelling during adaptive cancer drug tolerance. ASCEPT Annual Scientific Meeting, Sydney, NSW Australia, 20-23 November 2023.
2023
Journal Article
H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase
Menon, Dinoop Ravindran, Hammerlindl, Heinz, Gimenez, Gregory, Hammerlindl, Sabrina, Zuegner, Elmar, Torrano, Joachim, Bordag, Natalie, Emran, Abdullah Al, Giam, Maybelline, Denil, Simon, Pavelka, Norman, Tan, Aik-Choon, Sturm, Richard A., Haass, Nikolas K., Rancati, Giulia, Herlyn, Meenhard, Magnes, Christoph, Eccles, Michael R., Fujita, Mayumi and Schaider, Helmut (2023). H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase. Drug Resistance Updates, 71 100993, 100993. doi: 10.1016/j.drup.2023.100993
2023
Conference Publication
High-plex spatial profiling of cutaneous squamous cell carcinoma to identify biomarkers associated with clinical outcomes: The cMIC study
Ladwa, R., Monkman, J., Sadeghirad, H., Cooper, C., Belz, G., Bowman, J., Schaider, H., Liu, H., Kulasinghe, A. and Porceddu, S. (2023). High-plex spatial profiling of cutaneous squamous cell carcinoma to identify biomarkers associated with clinical outcomes: The cMIC study. ESMO Congress 2023, Madrid, Spain, 20-24 October 2023. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2023.09.2278
2023
Conference Publication
1244 Epigenetic and metabolic vulnerabilities of adaptive drug resistance to targeted therapies in melanoma
Torrano, J., Ravindran-Menon, D., Hammerlindl, H., Hammerlindl, S., Emran, A.A., Bordag, N., Zuegner, E., Haass, N.K., Sadowski, M., Stow, J., Magnes, C., Fujita, M. and Schaider, H. (2023). 1244 Epigenetic and metabolic vulnerabilities of adaptive drug resistance to targeted therapies in melanoma. 1st International Societies for Investigative Dermatology Meeting (ISID 2023), Tokyo, Japan, 10-13 May 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2023.03.1258
2023
Conference Publication
Anatomical distribution of severe keratinocyte carcinomas in solid organ transplant recipients
Cox, Charlotte, Lee, Ruby, Liyanage, Upekha, Brown, Susan, Isbel, Nicole, Chambers, Daniel, Griffin, Anthony, Campbell, Scott, Hopkins, Peter, Schaider, Helmut, Soyer, Peter and Khosrotehrani, Kiarash (2023). Anatomical distribution of severe keratinocyte carcinomas in solid organ transplant recipients. HOBOKEN: WILEY.
2023
Conference Publication
Distinct HOX gene family DNA methylation profiles in histologically normal skin dependent on dermoscopic pattern of adjacent nevi
Muse, Meghan E., Schaider, Helmut, Oey, Harald, Soyer, H. Peter, Christensen, Brock C. and Stark, Mitchell S. (2023). Distinct HOX gene family DNA methylation profiles in histologically normal skin dependent on dermoscopic pattern of adjacent nevi. 114th Annual Meeting of the American Association for Cancer Research (AACR), Orlando Fl, Apr 14-19, 2023. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1538-7445.AM2023-6000
2023
Conference Publication
MITF-mediated changes of tumour architecture, tensile stress and in extracellular matrix (ECM) control intratumour heterogeneity in melanoma
Spoerri, L., Tonnessen-Murray, C. A., Beaumont, K. A., Hill, D. S., Jurek, R. J., Gunasingh, G., Vanwalleghem, G., Daignault, S., Fane, M. E., Schaider, H., Smith, A., Stehbens, S. J., Weninger, W., Scott, E. E., Gabrielli, B. and Haass, N. (2023). MITF-mediated changes of tumour architecture, tensile stress and in extracellular matrix (ECM) control intratumour heterogeneity in melanoma. Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF), Berlin, Germany, 11-14 March 2020. Chichester, West Sussex United Kingdom: Wiley-Blackwell.
2023
Journal Article
Distinct HOX gene family DNA methylation profiles in histologically normal skin dependent on dermoscopic pattern of adjacent nevi
Muse, Meghan E., Schaider, Helmut, Oey, Harald, Soyer, H. Peter, Christensen, Brock C. and Stark, Mitchell S. (2023). Distinct HOX gene family DNA methylation profiles in histologically normal skin dependent on dermoscopic pattern of adjacent nevi. Journal of Investigative Dermatology, 143 (9), 1830-1834. doi: 10.1016/j.jid.2023.03.1653
2023
Journal Article
Three‐dimensional multispectral facial imaging to monitor actinic damage treated with 5‐fluorouracil
Torrano, Joachim, Hishon, Matt, Robinson, Mitchell, Raphael, Anthony, Wu, Jason, Betz‐Stablein, Brigid, Kopera, Daisy, Soyer, Hans Peter and Schaider, Helmut (2023). Three‐dimensional multispectral facial imaging to monitor actinic damage treated with 5‐fluorouracil. JEADV Clinical Practice, 2 (2), 273-281. doi: 10.1002/jvc2.122
2023
Journal Article
Nicotinamide for skin-cancer chemoprevention in transplant recipients
Allen, Nicholas C., Martin, Andrew J., Snaidr, Victoria A., Eggins, Renee, Chong, Alvin H., Fernandéz-Peñas, Pablo, Gin, Douglas, Sidhu, Shireen, Paddon, Vanessa L., Banney, Leith A., Lim, Adrian, Upjohn, Edward, Schaider, Helmut, Ganhewa, Aparna D., Nguyen, Jennifer, Mckenzie, Catriona A., Prakash, Saurabh, Mclean, Catriona, Lochhead, Alistair, Ibbetson, Jan, Dettrick, Andrew, Landgren, Anthony, Allnutt, Katherine J., Allison, Clare, Davenport, Rachael B., Mumford, Blake P., Wong, Brittany, Stagg, Brendan, Tedman, Alexander ... Damian, Diona L. (2023). Nicotinamide for skin-cancer chemoprevention in transplant recipients. New England Journal of Medicine, 388 (9), 804-812. doi: 10.1056/NEJMoa2203086
2023
Journal Article
Tribute to reviewers
Khosrotehrani, Kiarash and Schaider, Helmut (2023). Tribute to reviewers. Australasian Journal of Dermatology, 64 (1), 162-166. doi: 10.1111/ajd.13990
2023
Journal Article
Skin cancer excisions and histopathology outcomes when following a contemporary population‐based cohort longitudinally with 3D total‐body photography
Soyer, H. Peter, O’Hara, Montana, V. Silva, Carina, Horsham, Caitlin, Jayasinghe, Dilki, Sanjida, Saira, Schaider, Helmut, Aitken, Joanne, Sturm, Richard A., Prow, Tarl, Menzies, Scott W. and Janda, Monika (2023). Skin cancer excisions and histopathology outcomes when following a contemporary population‐based cohort longitudinally with 3D total‐body photography. Skin Health and Disease, 3 (2) e216, e216. doi: 10.1002/ski2.216
2022
Journal Article
Genome-scale DNA methylation analysis identifies repeat element alterations that modulate the genomic stability of melanocytic nevi
Muse, Meghan E., Bergman, Drew T., Salas, Lucas A., Tom, Lisa N., Tan, Jean-Marie, Laino, Antonia, Lambie, Duncan, Sturm, Richard A., Schaider, Helmut, Soyer, H. Peter, Christensen, Brock C. and Stark, Mitchell S. (2022). Genome-scale DNA methylation analysis identifies repeat element alterations that modulate the genomic stability of melanocytic nevi. The Journal of Investigative Dermatology, 142 (7), 1893-1902.e7. doi: 10.1016/j.jid.2021.11.025
Funding
Current funding
Supervision
Availability
- Associate Professor Helmut Schaider is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Chemoprevention of Melanoma using natural products and TRAIL- based therapeutics.
Associate Advisor
Other advisors: Professor Brian Gabrielli, Professor Peter Soyer, Dr Zyta M Ziora, Dr Jazmina Gonzalez Cruz
-
Doctor Philosophy
Proteomics and transcriptomics analysis of phenotypic heterogeneity in 3D melanoma spheroids
Associate Advisor
Other advisors: Dr Quan Nguyen, Professor Nikolas Haass
-
Doctor Philosophy
Proteomics and transcriptomics analysis of phenotypic heterogeneity in 3D melanoma spheroids
Associate Advisor
Other advisors: Dr Quan Nguyen, Professor Nikolas Haass
Completed supervision
-
2020
Master Philosophy
The role of SETDB1/2-mediated H3K9me3 in drug-tolerant cancer
Principal Advisor
-
2019
Doctor Philosophy
Characterizing therapy induced adaptive phenotypic plasticity leading to acquired drug resistance in cancer
Principal Advisor
Other advisors: Professor David Craik
-
2018
Doctor Philosophy
Distinct Epigenetic Modifications Denote Early Drug Resistance in Cancer
Principal Advisor
Other advisors: Professor Brian Gabrielli
-
2018
Master Philosophy
The correlation of skin colour, skin reflectance, freckling, MC1R, TYR, IRF-4 and TPCN2 genotypes with naevus pattern within a case-control study of melanoma
Principal Advisor
-
2017
Master Philosophy
The role of immune regulators in induced drug tolerant cells (IDTC) in melanoma
Principal Advisor
Other advisors: Associate Professor James Wells
-
2020
Master Philosophy
Resistance to therapy in metastatic melanoma: Comparing the expression of immune inhibitory modulators in vitro with refractory metastatic melanoma patients.
Associate Advisor
Other advisors: Associate Professor James Wells
-
2020
Doctor Philosophy
An evaluation of the role of locoregional treatments for the management of in-transit melanoma metastases
Associate Advisor
Other advisors: Professor Peter Soyer
-
2020
Doctor Philosophy
Enhanced topical drug delivery for treatment of human melanoma
Associate Advisor
Other advisors: Emeritus Professor Ross Barnard, Emeritus Professor Michael Roberts, Associate Professor Yousuf Mohammed
-
2019
Doctor Philosophy
Investigation of Microphthalmia-Associated Transcription Factor (MITF)-driven tumour heterogeneity in a 3D melanoma spheroid model in vitro.
Associate Advisor
Other advisors: Professor Nikolas Haass
-
2019
Master Philosophy
Dissecting Molecular Events in Pregnancy-Associated Melanoma
Associate Advisor
Other advisors: Professor Kiarash Khosrotehrani
Media
Enquiries
For media enquiries about Associate Professor Helmut Schaider's areas of expertise, story ideas and help finding experts, contact our Media team: